These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience. Cescon M, Cucchetti A, Grazi GL, Ferrero A, Viganò L, Ercolani G, Ravaioli M, Zanello M, Andreone P, Capussotti L, Pinna AD. Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357 [Abstract] [Full Text] [Related]
46. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma. Kubo S, Takemura S, Tanaka S, Shinkawa H, Nishioka T, Nozawa A, Kinoshita M, Hamano G, Ito T, Urata Y. World J Gastroenterol; 2015 Jul 21; 21(27):8249-55. PubMed ID: 26217076 [Abstract] [Full Text] [Related]
47. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, Watanabe T, Mine T, Tokai RFA Study Group. Cancer; 2010 Aug 01; 116(15):3638-44. PubMed ID: 20564097 [Abstract] [Full Text] [Related]
48. Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma. Jang JW, Choi JY, Bae SH, Kim CW, Yoon SK, Cho SH, Yang JM, Ahn BM, Lee CD, Lee YS, Chung KW, Sun HS. J Hepatol; 2004 Sep 01; 41(3):427-35. PubMed ID: 15336446 [Abstract] [Full Text] [Related]
49. Transarterial chemoembolization for hepatitis B virus-associated hepatocellular carcinoma: improved survival after concomitant treatment with nucleoside analogues. Toyoda H, Kumada T, Tada T, Sone Y, Fujimori M. J Vasc Interv Radiol; 2012 Mar 01; 23(3):317-22.e1. PubMed ID: 22265248 [Abstract] [Full Text] [Related]
50. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma. Sohn W, Paik YH, Kim JM, Kwon CH, Joh JW, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Ann Surg Oncol; 2014 Jul 01; 21(7):2429-35. PubMed ID: 24619495 [Abstract] [Full Text] [Related]
54. Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma. Lin CI, Lin ZY, Hsieh MY, Huang CF, Chen SH, Chuang WL. Kaohsiung J Med Sci; 2011 Dec 01; 27(12):554-9. PubMed ID: 22208538 [Abstract] [Full Text] [Related]
58. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. Feng K, Yan J, Li X, Xia F, Ma K, Wang S, Bie P, Dong J. J Hepatol; 2012 Oct 01; 57(4):794-802. PubMed ID: 22634125 [Abstract] [Full Text] [Related]